AVITA Medical (RCEL) Competitors $9.23 +0.28 (+3.13%) Closing price 04:00 PM EasternExtended Trading$9.22 -0.01 (-0.11%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCEL vs. AXGN, EMBC, BVS, RXST, CBLL, IRMD, AVNS, SIBN, KIDS, and BFLYShould you be buying AVITA Medical stock or one of its competitors? The main competitors of AVITA Medical include AxoGen (AXGN), Embecta (EMBC), Bioventus (BVS), RxSight (RXST), CeriBell (CBLL), Iradimed (IRMD), Avanos Medical (AVNS), SI-BONE (SIBN), OrthoPediatrics (KIDS), and Butterfly Network (BFLY). These companies are all part of the "medical equipment" industry. AVITA Medical vs. AxoGen Embecta Bioventus RxSight CeriBell Iradimed Avanos Medical SI-BONE OrthoPediatrics Butterfly Network AVITA Medical (NASDAQ:RCEL) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations. Which has more volatility and risk, RCEL or AXGN? AVITA Medical has a beta of 1.6, meaning that its share price is 60% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500. Does the MarketBeat Community believe in RCEL or AXGN? AxoGen received 374 more outperform votes than AVITA Medical when rated by MarketBeat users. Likewise, 72.89% of users gave AxoGen an outperform vote while only 70.34% of users gave AVITA Medical an outperform vote. CompanyUnderperformOutperformAVITA MedicalOutperform Votes8370.34% Underperform Votes3529.66% AxoGenOutperform Votes45772.89% Underperform Votes17027.11% Which has stronger valuation and earnings, RCEL or AXGN? AxoGen has higher revenue and earnings than AVITA Medical. AxoGen is trading at a lower price-to-earnings ratio than AVITA Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAVITA Medical$64.25M3.77-$61.85M-$2.39-3.86AxoGen$187.34M3.70-$21.72M-$0.22-71.14 Do analysts prefer RCEL or AXGN? AVITA Medical currently has a consensus price target of $17.25, indicating a potential upside of 86.89%. AxoGen has a consensus price target of $22.60, indicating a potential upside of 44.41%. Given AVITA Medical's higher probable upside, research analysts plainly believe AVITA Medical is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AVITA Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75AxoGen 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer RCEL or AXGN? In the previous week, AxoGen had 4 more articles in the media than AVITA Medical. MarketBeat recorded 8 mentions for AxoGen and 4 mentions for AVITA Medical. AxoGen's average media sentiment score of 1.29 beat AVITA Medical's score of 0.47 indicating that AxoGen is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AVITA Medical 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral AxoGen 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in RCEL or AXGN? 27.7% of AVITA Medical shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 1.8% of AVITA Medical shares are held by insiders. Comparatively, 7.0% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Is RCEL or AXGN more profitable? AxoGen has a net margin of -7.91% compared to AVITA Medical's net margin of -96.26%. AxoGen's return on equity of -14.91% beat AVITA Medical's return on equity.Company Net Margins Return on Equity Return on Assets AVITA Medical-96.26% -337.91% -71.50% AxoGen -7.91%-14.91%-7.49% SummaryAxoGen beats AVITA Medical on 14 of the 18 factors compared between the two stocks. Remove Ads Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAVITA MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$241.99M$4.07B$5.33B$7.57BDividend YieldN/A39.50%5.11%4.32%P/E Ratio-3.8627.6321.7317.81Price / Sales3.7750.20379.2094.61Price / CashN/A51.0838.1534.64Price / Book54.295.826.464.00Net Income-$61.85M$67.09M$3.20B$247.23M7 Day Performance20.34%5.64%6.54%7.26%1 Month Performance7.95%-3.20%-8.55%-6.26%1 Year Performance-2.43%14.87%10.33%-0.18% AVITA Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAVITA Medical1.4517 of 5 stars$9.23+3.1%$17.25+86.9%-9.4%$241.99M$64.25M-3.86130Gap DownAXGNAxoGen2.9597 of 5 stars$16.62+2.5%$22.60+36.0%+122.7%$737.00M$187.34M-51.94450Short Interest ↑News CoveragePositive NewsGap DownEMBCEmbecta4.5228 of 5 stars$12.09+0.8%$23.00+90.2%+16.1%$702.84M$1.11B12.091,900Gap DownHigh Trading VolumeBVSBioventus3.2365 of 5 stars$8.27-0.7%$15.00+81.4%+73.3%$677.68M$573.28M-13.561,200News CoveragePositive NewsGap DownRXSTRxSight3.0115 of 5 stars$16.61+2.2%$43.78+163.6%-73.8%$672.56M$139.93M-20.01220Analyst ForecastGap DownHigh Trading VolumeCBLLCeriBellN/A$18.19-1.4%$32.50+78.7%N/A$652.44M$65.44M0.00N/ANews CoverageGap DownIRMDIradimed4.8755 of 5 stars$49.37-1.1%$72.00+45.8%+28.4%$627.74M$73.24M32.91110Short Interest ↓News CoveragePositive NewsAVNSAvanos Medical3.2236 of 5 stars$12.88-4.0%N/A-32.9%$592.43M$687.80M37.884,040Positive NewsHigh Trading VolumeSIBNSI-BONE4.0648 of 5 stars$13.47flat$24.40+81.1%-10.8%$571.84M$167.18M-14.64350Positive NewsGap DownKIDSOrthoPediatrics4.3197 of 5 stars$21.80-4.0%$37.20+70.6%-32.5%$529.46M$204.73M-17.72200Positive NewsHigh Trading VolumeBFLYButterfly Network1.5188 of 5 stars$2.08+1.7%$3.00+44.6%+184.5%$504.07M$82.06M-4.51460Positive News Remove Ads Related Companies and Tools Related Companies AxoGen Alternatives Embecta Alternatives Bioventus Alternatives RxSight Alternatives CeriBell Alternatives Iradimed Alternatives Avanos Medical Alternatives SI-BONE Alternatives OrthoPediatrics Alternatives Butterfly Network Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCEL) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
